Logo image
Previous coronary artery bypass graft is not associated with higher mortality in transcatheter aortic valve replacement: systemic review and meta-analysis
Journal article

Previous coronary artery bypass graft is not associated with higher mortality in transcatheter aortic valve replacement: systemic review and meta-analysis

N. Prasitlumkum, J. Kewcharoen, C. Kanitsoraphan, P. Rattanawong, R. Mekritthikrai, E.A. Gillaspie, M.A. Mao and W. Cheungpasitporn
Acta Cardiologica, Vol.75(1), pp.26-34
2020

Abstract

Coronary artery bypass meta-analysis mortality systematic reviews transcatheter aortic valve replacement Aged Aged, 80 and over Aortic Valve Stenosis Cause of Death Coronary Artery Bypass Coronary Artery Disease Female Humans Male Risk Assessment Risk Factors Severity of Illness Index Time Factors Transcatheter Aortic Valve Replacement Treatment Outcome all cause mortality aortic valve replacement artery bypass Article cardiovascular disease cardiovascular mortality coronary artery coronary artery bypass graft human incidence meta analysis mortality mortality rate outcome assessment Publication quality control risk factor sensitivity analysis systematic review transcatheter aortic valve implantation adverse event aged aortic valve stenosis cause of death coronary artery bypass graft coronary artery disease diagnostic imaging female male risk assessment severity of illness index time factor transcatheter aortic valve implantation treatment outcome very elderly
Introduction: Patients with previous coronary artery bypass graft (CABG) are usually considered as high-risk groups perioperatively. Recent studies suggest that previous CABG is not associated with mortality in patients with severe aortic stenosis (AS) who underwent transcatheter aortic valve replacement (TAVR). However, systematic review and meta-analysis of the literature has not been done. Thus, we conducted this systematic review and meta-analysis to assess the association between previous CABG and mortality in patients undergoing TAVR. Methods: We comprehensively searched the databases of MEDLINE and EMBASE from inception to July 2018. Included studies were published prospective or retrospective cohort studies that evaluated the effects of previous CABG status on mortality risk among patients undergoing TAVR. Data from each study were combined using the random-effects, generic inverse variance method of DerSimonian and Laird to calculate risk ratios and 95% confidence intervals. Results: Eleven cohort studies from March 2010 to April 2018 were included in this meta-analysis involving 7299 subjects with severe AS undergoing TAVR (1890 with and 5409 without previous CABG). Previous CABG was not associated with all-cause mortality (pooled risk ratio = 0.96, 95% confidence interval: 0.80–1.16, p=.66, I2=21%) and cardiovascular (CV) mortality (pooled risk ratio = 1.23, 95% confidence interval: 0.64–2.39, p=.72, I2=35%). Conclusions: Previous CABG is not associated with either all-cause mortality or CV mortality in patients with severe AS undergoing TAVR. TAVR should be considered as an alternative or first-line treatment option among severe AS patient, regardless of previous CABG status. © 2019, © 2019 Belgian Society of Cardiology.
url
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060147566&doi=10.1080%2f00015385.2018.1541845&partnerID=40&md5=40cc0bff08185dfe908bcbada7a16e31View

Metrics

4 Record Views

Details

Logo image